Abstract
Recent research has demonstrated that microRNAs (miRNAs) are key regulators of many cell processes often deregulated in cancer, including apoptosis. Indeed, it is becoming clear that many miRNAs are anti-apoptotic and mediate this effect by targeting pro-apoptotic mRNAs or positive regulators of pro-apoptotic mRNAs. Conversely, many pro-apoptotic miRNAs target anti-apoptotic mRNAs or their positive regulators. We have reviewed the current knowledge in this area including evidence of miRNA involvement in cancer drug resistance.
MeSH Terms
Antineoplastic Agents/therapeutic use
Apoptosis/genetics
Apoptosis Regulatory Proteins/antagonists & inhibitors
CASP8 and FADD-Like Apoptosis Regulating Protein/physiology
Caspase 9/metabolism
Down-Regulation
Drug Resistance, Neoplasm/genetics
Humans
Intracellular Signaling Peptides and Proteins/physiology
MicroRNAs/physiology
Myeloid Cell Leukemia Sequence 1 Protein
Neoplasms/drug therapy,genetics
Peptide Fragments/metabolism
Phosphoproteins/physiology
Proto-Oncogene Proteins/metabolism
Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors,metabolism
Tumor Suppressor Protein p53/metabolism
bcl-X Protein/antagonists & inhibitors
Chemicals
Antineoplastic Agents
Apoptosis Regulatory Proteins
BCL2L1 protein, human
BCL2L2 protein, human
Bax protein (53-86)
CASP8 and FADD-Like Apoptosis Regulating Protein
CFLAR protein, human
Intracellular Signaling Peptides and Proteins
MicroRNAs
Myeloid Cell Leukemia Sequence 1 Protein
PEA15 protein, human
Peptide Fragments
Phosphoproteins
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
Tumor Suppressor Protein p53
bcl-X Protein
Caspase 9
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Lima Raquel T
IPATIMUP, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.
Busacca Sara
Almeida Gabriela M
Gaudino Giovanni
Fennell Dean A
Vasconcelos M Helena